Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: PR Newswire
WASHINGTON, April 30, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards, single use tangential flow filtration systems, and stainless steel hollow fiber tangential flow filtration systems businesses to Sartorius AG for approximately $825 million. The combined revenue of the businesses, which were part of Danaher's Life Sciences segment, was approximately $170 million in 2019.Danaher sold these businesses in order to obtain regulatory approval for its acquisition of the GE Biopharma business, now called Cytiva. The closing of the Sartorius AG agreement was conditioned upon Danaher closing its acquisition of Cytiva, which was completed on March 31, 2020. ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher Corporation (DHR) Maintains Buy Rating as Analysts See Upside in 2026 [Yahoo! Finance]Yahoo! Finance
- Danaher (NYSE:DHR) had its price target raised by analysts at Leerink Partners from $260.00 to $270.00. They now have an "outperform" rating on the stock.MarketBeat
- Danaher (DHR) Rebounded on Accelerated Demand [Yahoo! Finance]Yahoo! Finance
- How Investors Are Reacting To Danaher (DHR) Upbeat 2025 Outlook And Growing Synthetic Biology Ambitions [Yahoo! Finance]Yahoo! Finance
- JPM26: Danaher positioned to improve patient diagnostics [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 10/21/25 - Beat
DHR
Sec Filings
- 1/12/26 - Form 8-K
- 12/31/25 - Form 4
- 11/26/25 - Form 4
- DHR's page on the SEC website